Literature DB >> 34368452

Epidemiology of Pancreatic Cancer in Puerto Rico (1987-2010): Incidence, Mortality and Survival.

M Castañeda-Ávila1, A Cruz-Benítez1, W Fuentes-Payán1, A Maldonado-Albertorio1, L Nieves-Ferrer1, P Padró-Juarbe1, R Soto-Abreu1, N Pérez-Ríos2, C R Torres-Cintrón2, K J Ortiz-Ortiz2, A P Ortiz Martinez1,3.   

Abstract

BACKGROUND &
OBJECTIVE: Pancreatic cancer is an uncommon type of cancer worldwide. Nonetheless, even with early diagnosis, mortality rates are high. This study aims to perform an epidemiologic profile of pancreatic cancer in Puerto Rico (PR) from 1987-2010.
METHODS: Using data from the Puerto Rico Central Cancer Registry, age-standardized incidence and mortality rates of pancreatic cancer in PR were compared with Hispanics, non-Hispanic Whites, and non-Hispanic Blacks in the United States of America (USA). Incidence and mortality trends of pancreatic cancer were estimated, and survival analyses were also performed.
RESULTS: In 2005-2010, 5.8 per 100,000 persons were diagnosed with pancreatic cancer in PR and mortality rates were similar. Pancreatic cancer was more frequent in men (6.5 per 100,000 men) than women (5.2 per 100,000 women), and in persons older than 65 years (32.0 per 100,000 persons). Moreover, the median survival for the people diagnosed with pancreatic cancer in PR during 2006-2007 was 4 months and at the end of the third year after diagnosis, only 13% of the patients survived. Incidence trends of pancreatic cancer showed an increase for men (APC=13.0%, p<0.05) from 2006 to 2010, but not for women (APC=-0.4, p>0.05). However, mortality trends showed a slight decrease for men (APC=-1.0%, p<0.05), but not for women (APC=1.4, p>0.05) in the period of 1987 to 2010. Meanwhile, Puerto Ricans in comparison to other racial/ethnic groups living in the USA showed a lower risk for being diagnosed and of dying from pancreatic cancer.
CONCLUSION: Our results highlight the need for additional research in pancreatic cancer, in order to have an impact in disease survival in PR.

Entities:  

Keywords:  Epidemiology; Incidence; Mortality; Pancreatic cancer; Puerto Rico

Year:  2016        PMID: 34368452      PMCID: PMC8341429     

Source DB:  PubMed          Journal:  Austin J Gastroenterol        ISSN: 2381-9219


  10 in total

1.  The epidemiology of pancreatic cancer in the United States: changes below the surface.

Authors:  Y H Shaib; J A Davila; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2006-07-01       Impact factor: 8.171

2.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

Review 3.  Epidemiology of pancreatic cancer: an overview.

Authors:  P Ghadirian; H T Lynch; D Krewski
Journal:  Cancer Detect Prev       Date:  2003

4.  Vital signs: current cigarette smoking among adults aged ≥18 years--United States, 2005-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-09-09       Impact factor: 17.586

5.  Productivity loss in Puerto Rico's labor market due to cancer mortality.

Authors:  Karen J Ortiz-Ortiz; Javier Pérez-Irizarry; Heriberto Marín-Centeno; Ana P Ortiz; Natalia Torres-Berrios; Mariela Torres-Cintrón; Taína de la Torre-Feliciano; José Laborde-Rivera; William A Calo; Nayda R Figueroa-Vallés
Journal:  P R Health Sci J       Date:  2010-09       Impact factor: 0.705

6.  Cancer disparities between mainland and island Puerto Ricans.

Authors:  Gloria Y F Ho; Nayda R Figueroa-Vallés; Taína De La Torre-Feliciano; Katherine L Tucker; Guillermo Tortolero-Luna; Winna T Rivera; Ivonne Z Jiménez-Velázquez; Ana Patricia Ortiz-Martínez; Thomas E Rohan
Journal:  Rev Panam Salud Publica       Date:  2009-05

Review 7.  Pancreatic cancer.

Authors:  Donghui Li; Keping Xie; Robert Wolff; James L Abbruzzese
Journal:  Lancet       Date:  2004-03-27       Impact factor: 79.321

Review 8.  Epidemiology and prevention of pancreatic cancer.

Authors:  Albert B Lowenfels; Patrick Maisonneuve
Journal:  Jpn J Clin Oncol       Date:  2004-05       Impact factor: 3.019

9.  Why do Black Americans have a higher risk of pancreatic cancer than White Americans?

Authors:  Debra T Silverman; Robert N Hoover; Linda M Brown; G Marie Swanson; Mark Schiffman; Raymond S Greenberg; Richard B Hayes; Keith D Lillemoe; Janet B Schoenberg; Ann G Schwartz; Jonathan Liff; Linda M Pottern; Joseph F Fraumeni
Journal:  Epidemiology       Date:  2003-01       Impact factor: 4.822

10.  Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity?

Authors:  Lauren D Arnold; Alpa V Patel; Yan Yan; Eric J Jacobs; Michael J Thun; Eugenia E Calle; Graham A Colditz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-01       Impact factor: 4.254

  10 in total
  1 in total

1.  SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro.

Authors:  Fengyun Zhao; Yanni Huang; Yingheng Zhang; Xun Li; Kaizhao Chen; Yihao Long; Fugui Li; Xiaodong Ma
Journal:  Mol Biol Rep       Date:  2022-05-12       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.